Literature DB >> 26069236

Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis.

Sanjana Dayal1, Sean X Gu2, Ryan D Hutchins2, Katina M Wilson2, Yi Wang2, Xiaoyun Fu2, Steven R Lentz2.   

Abstract

OBJECTIVE: Clinical evidence suggests an association between oxidative stress and vascular disease, and in vitro studies have demonstrated that reactive oxygen species can have prothrombotic effects on vascular and blood cells. It remains unclear, however, whether elevated levels of reactive oxygen species accelerate susceptibility to experimental thrombosis in vivo. APPROACH AND
RESULTS: Using a murine model with genetic deficiency in superoxide dismutase-1 (SOD1), we measured susceptibility to carotid artery thrombosis in response to photochemical injury. We found that SOD1-deficient (Sod1(-/-)) mice formed stable arterial occlusions significantly faster than wild-type (Sod1(+/+)) mice (P<0.05). Sod1(-/-) mice also developed significantly larger venous thrombi than Sod1(+/+) mice after inferior vena cava ligation (P<0.05). Activation of protein C by thrombin in lung was diminished in Sod1(-/-) mice (P<0.05 versus Sod1(+/+) mice), and generation of activated protein C in response to infusion of thrombin in vivo was decreased in Sod1(-/-) mice (P<0.05 versus Sod1(+/+) mice). SOD1 deficiency had no effect on the expression of thrombomodulin, endothelial protein C receptor, or tissue factor in lung or levels of protein C in plasma. Exposure of human thrombomodulin to superoxide in vitro caused oxidation of multiple methionine residues, including critical methionine 388, and a 40% decrease in thrombomodulin-dependent activation of protein C (P<0.05). SOD and catalase protected against superoxide-induced methionine oxidation and restored protein C activation in vitro (P<0.05).
CONCLUSIONS: SOD prevents thrombomodulin methionine oxidation, promotes protein C activation, and protects against arterial and venous thrombosis in mice.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  catalase; protein C; superoxides; thrombomodulin; thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26069236      PMCID: PMC4514539          DOI: 10.1161/ATVBAHA.115.305963

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  45 in total

1.  NMR structures reveal how oxidation inactivates thrombomodulin.

Authors:  Matthew J Wood; L Amaya Becvar; Judith Helena Prieto; Giuseppe Melacini; Elizabeth A Komives
Journal:  Biochemistry       Date:  2003-10-21       Impact factor: 3.162

2.  Characterization of a mouse model for thrombomodulin deficiency.

Authors:  H Weiler; V Lindner; B Kerlin; B H Isermann; S B Hendrickson; B C Cooley; D A Meh; M W Mosesson; N W Shworak; M J Post; E M Conway; L H Ulfman; U H von Andrian; J I Weitz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

3.  Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice.

Authors:  Sean P Didion; Michael J Ryan; Lisa A Didion; Pamela E Fegan; Curt D Sigmund; Frank M Faraci
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

Review 4.  Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities.

Authors:  Patrizia Ferroni; Natale Vazzana; Silvia Riondino; Chiara Cuccurullo; Fiorella Guadagni; Giovanni Davì
Journal:  Antioxid Redox Signal       Date:  2012-05-08       Impact factor: 8.401

5.  Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease.

Authors:  Zehra Serdar; Kemal Aslan; Melahat Dirican; Emre Sarandöl; Dilek Yeşilbursa; Akýn Serdar
Journal:  Clin Biochem       Date:  2006-04-05       Impact factor: 3.281

Review 6.  Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?

Authors:  Bonno N Bouma; Laurent O Mosnier
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

7.  NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.

Authors:  Juan Manuel Ramiro-Diaz; Carlos H Nitta; Levi D Maston; Simon Codianni; Wieslawa Giermakowska; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-08       Impact factor: 5.464

8.  Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus.

Authors:  R De Cristofaro; B Rocca; E Vitacolonna; A Falco; P Marchesani; G Ciabattoni; R Landolfi; C Patrono; G Davì
Journal:  J Thromb Haemost       Date:  2003-02       Impact factor: 5.824

9.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.

Authors:  F J Miller; D D Gutterman; C D Rios; D D Heistad; B L Davidson
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

Review 10.  Vascular protection: superoxide dismutase isoforms in the vessel wall.

Authors:  Frank M Faraci; Sean P Didion
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-27       Impact factor: 8.311

View more
  8 in total

Review 1.  Thrombotic Regulation From the Endothelial Cell Perspectives.

Authors:  Miao Wang; Huifeng Hao; Nicholas J Leeper; Liyuan Zhu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06       Impact factor: 8.311

2.  Oxidative status and antioxidant enzyme levels in deep venous thrombosis patients.

Authors:  Fevzi Sarper Türker; Ayşe Malbora; Mine Erisir
Journal:  Am J Cardiovasc Dis       Date:  2021-02-20

Review 3.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

4.  Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients.

Authors:  Katharina Bell; Vanessa M Beutgen; Stefan Nickels; Katrin Lorenz; Yvonne Scheller; Hisham Elbaz; Tunde Peto; Katharina A Ponto; Andreas Schulz; Philipp S Wild; Thomas Münzel; Karl J Lackner; Irene Schmidtmann; Manfred Beutel; Norbert Pfeiffer; Franz H Grus; Alexander K Schuster
Journal:  J Ophthalmol       Date:  2020-07-29       Impact factor: 1.909

5.  Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in mice.

Authors:  Vijay K Sonkar; Rahul Kumar; Melissa Jensen; Brett A Wagner; Anjali A Sharathkumar; Francis J Miller; MaryBeth Fasano; Steven R Lentz; Garry R Buettner; Sanjana Dayal
Journal:  Blood Adv       Date:  2019-04-23

Review 6.  Reactive Oxygen Species in Venous Thrombosis.

Authors:  Clemens Gutmann; Richard Siow; Adam M Gwozdz; Prakash Saha; Alberto Smith
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

Review 7.  Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases.

Authors:  Giovanna Petrucci; Alessandro Rizzi; Duaa Hatem; Giulia Tosti; Bianca Rocca; Dario Pitocco
Journal:  Antioxidants (Basel)       Date:  2022-07-20

Review 8.  Oxidative Cysteine Modification of Thiol Isomerases in Thrombotic Disease: A Hypothesis.

Authors:  Moua Yang; Robert Flaumenhaft
Journal:  Antioxid Redox Signal       Date:  2021-09-13       Impact factor: 8.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.